Skip to main content
TipRanks
Go Ultimate75% OFF

Spirax Group (SPXSF) AI Stock Analysis

0 Followers
SPXSF

Spirax Group

(Other OTC:SPXSF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Diversified, recurring industrial modelExposure to multiple industrial end markets reduces dependence on any single customer sector, while replacement parts, consumables and services add recurring revenue. Application engineering and operationally critical products can support customer retention and more durable earnings across investment cycles.
Negative Factors
Multi-year margin and return compressionThe prolonged decline in net and EBIT margins shows that profitability has weakened despite broadly stable revenue. If costs, mix or pricing pressure persist, lower earnings conversion could constrain reinvestment, reduce returns and make recovery toward prior profitability levels harder.

Spirax Group (SPXSF) vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%SPXSF+12.83%SPY+13.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$5.48B
Dividend Yield
2.44%
Average Volume (3M)
742
Price to Earnings (P/E)
27.7
Beta (1Y)
1.09
Revenue Growth
8.99%
EPS Growth
26.32%
Country
US
Employees
10,000
Sector
Industrials
Sector Strength
63
Industry
Industrial - Machinery

Spirax Group Business Overview & Revenue Model

Company Description

Spirax-Sarco Engineering plc, founded in 1888 and headquartered in Cheltenham, UK, delivers sophisticated engineered solutions across several core technological domains. The company specializes in comprehensive industrial and commercial steam systems...

Spirax Group Earnings Call Summary

Earnings Call Date:Aug 11, 2026(Q2-2026)|% Change Since:-3.80%|Next Earnings Date:Mar 11, 2027
Earnings Call SentimentPositive

The call presents a broadly positive performance: the group delivered mid‑single‑digit organic sales and profit growth, with notable margin progression in ETS and Watson‑Marlow, improved ROCE, strong order books, and reiterated medium‑term targets. Short‑term headwinds include STS margin phasing, inventory builds for geopolitical risk (reducing H1 cash conversion), temporary leverage slightly above the target range, and exposure to weak industrial production and FX movements. Management highlighted concrete operational and commercial initiatives (digital connections, decarbonization, localized production, and sales reinvestment) that support confidence in delivering full‑year guidance and medium‑term targets. Overall, the positive execution and pipeline momentum outweigh the transitory challenges communicated.

Positive Updates

Organic Sales Growth Outperforming Industrial Production
Group organic sales grew 5% in H1, well ahead of Industrial Production (IP) at 1.5%, demonstrating demand generation and market outperformance across all three businesses.

Negative Updates

STS Margin and Operating Profit Pressure in H1
STS adjusted operating profit declined 6% organically in H1 and adjusted operating margin fell c.170 basis points to 22%, largely due to shipment phasing (customers specifying H2 deliveries) and first‑half weighted investments in sales headcount and digital capabilities.

Company Guidance

Management reiterated full‑year guidance and said the group is on track, expecting higher H2 volumes and margin progression (typical adjusted operating profit weighting c.45% H1 / 55% H2). Key metrics: H1 organic sales +5% (vs IP +1.5%), organic operating profit +6%, adjusted operating margin 19.8% (up 10bps organically), adjusted EPS +9% to 150p, adjusted cash from operations £92m (H1 cash conversion 54%; full‑year cash conversion expected ~90%), H1 CapEx ~3% of sales with full‑year CapEx to be at the lower end of the 4–5% guidance, net debt £618m (net debt/EBITDA 1.6x; target 1.0–1.5x by year‑end), and ROCE >35% (up 180bps). Division outlooks: STS H1 sales +1% with stronger H2 and medium‑term margin target 23.5%; ETS H1 sales +11% with margin 17.2% (up 220bps) and a 20% margin target; Watson‑Marlow H1 sales +7% with margin 27.5% (up 80bps) and a path to >30%. FX assumed to have negligible full‑year revenue/profit impact (H1 profit had ~+2% FX tailwind; expect ~-2% H2 headwind).

Spirax Group Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

SPXSF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:RORGB:ROR78OutperformGBP 4.02B33.1221.48%1.69%2.22%25.89%
GB:IMIGB:IMI70OutperformGBP 6.62B20.8532.41%1.24%7.67%45.97%
GB:BOYGB:BOY64NeutralGBP 1.56B27.049.30%2.53%1.68%111.96%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
GB:WEIRGB:WEIR62NeutralGBP 5.88B22.3513.45%1.85%5.84%-14.62%
GB:SMINGB:SMIN61NeutralGBP 7.14B4.1892.97%1.84%-33.55%4.29%

* Industrials Sector Average

Performance Comparison

0%20%40%60%SPXSFGB:BOYGB:IMIGB:RORGB:SMINGB:WEIRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SPXSF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SPXSFSpirax Group Plc98.0711.8713.78%
GB:BOYBodycote plc919.50335.8157.53%
GB:IMIIMI plc2856.00496.2021.03%
GB:RORRotork (ROR)493.20162.8849.31%
GB:SMINSmiths Group plc2630.00243.0510.18%
GB:WEIRWeir Group plc (The)2280.00-398.28-14.87%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.